Drug Profile
Influenza virus DNA vaccine - PowderMed
Alternative Names: Influenza virus vaccine - PowderMed; PF-4522625Latest Information Update: 25 Apr 2009
Price :
$50
*
At a glance
- Originator PowderMed
- Class Antivirals; Influenza virus DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 03 Oct 2006 Phase-I clinical trials in Influenza virus infections in USA (Intradermal)
- 03 Oct 2006 PowderMed has initiated enrolment in a phase I trial for Influenza Virus Infections in the United Kingdom
- 08 Jun 2006 Phase I data have been added to the adverse events and Viral Infections immunogenicity section